Investigation of Southern Tick-Associated Rash Illness (STARI)
NCT00358761 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3
Last updated 2019-12-17
Summary
This study will evaluate blood and tissue samples for a condition called Southern Tick-Associated Rash Illness (STARI). This is a skin rash resembling erythema migrans, the rash found in people infected with Lyme disease. In the south and southeastern United States, STARI is associated with the bite of the lone star tick. Researchers seek a better understanding of the cause of STARI. Through researchers' knowledge, diagnostic tests could be developed. NIH is conducting this study along with the Centers for Disease Control and Prevention (CDC).
Patients ages 14 years and older who have recently been diagnosed with possible STARI, who have not taken antibiotics for it longer than 1 day, and whose skin does not form large scars may be eligible for this study. About 20 participants will be enrolled over a 5-year period. Patients will visit the NIH Clinical Center for two or three visits. The first visit may last 2 hours. Photographs will be taken of the rash, and a blood sample of about 1-1/2 tablespoons will be collected for tests. Patients will undergo a punch biopsy of three small pieces of skin, from the rash. The area of the skin will be cleaned, and patients will receive a local anesthetic at the biopsy site. A sharp instrument will remove a round plug of skin, about the size of half a pencil eraser. Patients may feel a pushing sensation, but there should not be pain. The site usually heals without sutures, though the doctors may close it with special adhesive bandages or one or two sutures. Patients will receive instructions about how to take care of the biopsy site. If sutures are used, patients will return in 7 to 10 days to have them removed-or a patient's own doctor may remove the sutures. Patients will return to NIH at 4 to 6 weeks following their first visit. At that time, they will answer questions about how they are doing and donate about 2 tablespoons of blood. Blood and skin samples will be used for research at NIH and CDC.
...
Conditions
- Southern Tick-Associated Rash Illness
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
Adriana R Marques, M.D. · National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility
- Min Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-07-20
- Completion
- 2012-12-11
Countries
- United States
Study Locations
More Related Trials
-
Initial and Chronic Methicillin Resistant Staphylococcus Aureus (MRSA) Infection in Cystic Fibrosis (CF)
NCT02684422 ·Status: COMPLETED
-
Human Immunity Against Staphylococcus Aureus Skin Infection
NCT02262819 ·Status: COMPLETED ·Phase: PHASE1
-
Livestock Contact and MRSA in Rural Areas
NCT01375621 ·Status: COMPLETED
-
A Multi-Site Clinical Evaluation of the ARIES Bordetella Assay in Symptomatic Patients
NCT02862262 ·Status: COMPLETED ·Phase: NA
-
Diagnosis and Staging of Typhoid Fever Using Surface-enhanced Raman Spectroscopy Liquid Biopsy
NCT06546982 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Azithromycin Plus Doxycycline Versus Doxycycline Plus Placebo in Patients With Rocky Mountain Spotted Fever
NCT05398055 ·Status: RECRUITING ·Phase: PHASE3
-
A Leukapheresis Study for Immune Responses in Healthy US Adults Who Receive BCG Vaccination Followed by Boosting With AERAS-402
NCT02375256 ·Status: COMPLETED ·Phase: PHASE1
-
GRoup A StrePtococcus
NCT01558804 ·Status: RECRUITING
-
Colonization, Infection, and Molecular Typing of Methicillin-Resistant Staphylococcus Aureus (MRSA) in Children.
NCT00254527 ·Status: COMPLETED
-
Eschar Investigations in Scrub Typhus
NCT02915861 ·Status: COMPLETED
-
Incidence of Group A Strep Pharyngitis in School Children in Fiji
NCT00284882 ·Status: COMPLETED
-
Th1/Th2 Polarization and Linkage to L. Viannia Infection Outcomes
NCT00401297 ·Status: COMPLETED
-
RNAseq Analysis of Microbial Gene Expression in Necrotizing Soft Tissue Infections
NCT02025816 ·Status: COMPLETED
-
Specificity Trial of the Recombinant Tuberculosis Allergen in BCG Vaccinated Healthy Volunteers
NCT05203068 ·Status: COMPLETED ·Phase: NA
-
Invasive Disease Caused by Group A Streptococcus (GAS) (DICAR)
NCT03507101 ·Status: UNKNOWN
-
Chart Review of Outcome of Treatment for S. Aureus Bacteremia
NCT00304902 ·Status: COMPLETED
-
Study of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTA
NCT01640886 ·Status: TERMINATED
-
Mechanisms Relating to the Distinct in Vitro Susceptibility of Human Macrophages to L. Viannia Infection
NCT00401557 ·Status: COMPLETED
-
Implementation of an RT-PCR Assay for the Diagnosis of Rickettsia Spp. Infection
NCT07307651 ·Status: NOT_YET_RECRUITING
-
Virulence Determinants in S Aureus Bacteremia
NCT00319826 ·Status: COMPLETED
-
Microbes and Respiratory Illnesses
NCT06059027 ·Status: COMPLETED
-
Clinical Research for the Diagnosis of Tick-borne Diseases in Patients With Unexplained Acute Fever
NCT02618655 ·Status: UNKNOWN
-
Pityriasis Lichenoides Chronica, Role of Streptococcal Infection and Azithromycin
NCT03831269 ·Status: UNKNOWN ·Phase: NA
-
Hospital Based Incidence of Group A Streptococcal Disease in Fiji
NCT00264771 ·Status: COMPLETED
-
Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections
NCT00633152 ·Status: COMPLETED ·Phase: PHASE2